188 related articles for article (PubMed ID: 18301122)
1. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression.
Williams LJ; Henry MJ; Berk M; Dodd S; Jacka FN; Kotowicz MA; Nicholson GC; Pasco JA
Int Clin Psychopharmacol; 2008 Mar; 23(2):84-7. PubMed ID: 18301122
[TBL] [Abstract][Full Text] [Related]
2. Rates of bone loss among women initiating antidepressant medication use in midlife.
Diem SJ; Ruppert K; Cauley JA; Lian Y; Bromberger JT; Finkelstein JS; Greendale GA; Solomon DH
J Clin Endocrinol Metab; 2013 Nov; 98(11):4355-63. PubMed ID: 24001746
[TBL] [Abstract][Full Text] [Related]
3. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
[TBL] [Abstract][Full Text] [Related]
4. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
[TBL] [Abstract][Full Text] [Related]
5. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
[TBL] [Abstract][Full Text] [Related]
6. The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis.
Schweiger JU; Schweiger U; Hüppe M; Kahl KG; Greggersen W; Jauch-Chara K; Fassbinder E
Int J Environ Res Public Health; 2018 Jun; 15(7):. PubMed ID: 29966324
[TBL] [Abstract][Full Text] [Related]
7. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
Diem SJ; Blackwell TL; Stone KL; Yaffe K; Haney EM; Bliziotes MM; Ensrud KE
Arch Intern Med; 2007 Jun; 167(12):1240-5. PubMed ID: 17592096
[TBL] [Abstract][Full Text] [Related]
8. Association of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density in Elderly Women.
Saraykar S; John V; Cao B; Hnatow M; Ambrose CG; Rianon N
J Clin Densitom; 2018; 21(2):193-199. PubMed ID: 28712980
[TBL] [Abstract][Full Text] [Related]
9. Normal Bone Microstructure and Density But Worse Physical Function in Older Women Treated with Selective Serotonin Reuptake Inhibitors, a Cross-Sectional Population-Based Study.
Larsson B; Mellström D; Johansson L; Nilsson AG; Lorentzon M; Sundh D
Calcif Tissue Int; 2018 Sep; 103(3):278-288. PubMed ID: 29730704
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.
Ak E; Bulut SD; Bulut S; Akdağ HA; Öter GB; Kaya H; Kaya OB; Şengül CB; Kısa C
Osteoporos Int; 2015 Jan; 26(1):273-9. PubMed ID: 25187118
[TBL] [Abstract][Full Text] [Related]
11. Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.
Calarge CA; Ellingrod VL; Zimmerman B; Bliziotes MM; Schlechte JA
J Clin Psychiatry; 2011 Dec; 72(12):1685-90. PubMed ID: 22244026
[TBL] [Abstract][Full Text] [Related]
12. Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men.
Williams LJ; Berk M; Hodge JM; Kotowicz MA; Stuart AL; Chandrasekaran V; Cleminson J; Pasco JA
Calcif Tissue Int; 2018 Aug; 103(2):125-130. PubMed ID: 29441424
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.
Calarge CA; Zimmerman B; Xie D; Kuperman S; Schlechte JA
J Clin Psychiatry; 2010 Mar; 71(3):338-47. PubMed ID: 20331935
[TBL] [Abstract][Full Text] [Related]
14. Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors.
Seifert CF; Wiltrout TR
Clin Ther; 2013 Sep; 35(9):1412-7. PubMed ID: 23958172
[TBL] [Abstract][Full Text] [Related]
15. Examining Whether Genetic Variants Moderate the Skeletal Effects of Selective Serotonin Reuptake Inhibitors in Older Adolescents and Young Adults.
Ezenwabachili I; Deumic Shultz E; Mills JA; Ellingrod V; Calarge CA
J Child Adolesc Psychopharmacol; 2023 Sep; 33(7):260-268. PubMed ID: 37579130
[No Abstract] [Full Text] [Related]
16. The adverse skeletal effects of selective serotonin reuptake inhibitors.
Tsapakis EM; Gamie Z; Tran GT; Adshead S; Lampard A; Mantalaris A; Tsiridis E
Eur Psychiatry; 2012 Apr; 27(3):156-69. PubMed ID: 21295451
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in adolescents with eating disorders exposed to selective serotonin reuptake inhibitors.
Couturier J; Sy A; Johnson N; Findlay S
Eat Disord; 2013; 21(3):238-48. PubMed ID: 23600554
[TBL] [Abstract][Full Text] [Related]
18. Use of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density Change: A Population-Based Longitudinal Study in Middle-Aged and Elderly Individuals.
Ham AC; Aarts N; Noordam R; Rivadeneira F; Ziere G; Zillikens MC; Tiemeier H; van der Velde N; Hofman A; Uitterlinden AG; Visser LE; Stricker BH
J Clin Psychopharmacol; 2017 Oct; 37(5):524-530. PubMed ID: 28816927
[TBL] [Abstract][Full Text] [Related]
19. SSRIs, bone mineral density, and risk of fractures--a review.
Schwan S; Hallberg P
Eur Neuropsychopharmacol; 2009 Oct; 19(10):683-92. PubMed ID: 19541458
[TBL] [Abstract][Full Text] [Related]
20. Effect of selective serotonin reuptake inhibitors on the risk of fracture.
Richards JB; Papaioannou A; Adachi JD; Joseph L; Whitson HE; Prior JC; Goltzman D;
Arch Intern Med; 2007 Jan; 167(2):188-94. PubMed ID: 17242321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
